BR0016012A - Implante farmacêutico contendo componentes de liberação imediata e de liberação prolongada, além de processo de administração - Google Patents

Implante farmacêutico contendo componentes de liberação imediata e de liberação prolongada, além de processo de administração

Info

Publication number
BR0016012A
BR0016012A BR0016012-1A BR0016012A BR0016012A BR 0016012 A BR0016012 A BR 0016012A BR 0016012 A BR0016012 A BR 0016012A BR 0016012 A BR0016012 A BR 0016012A
Authority
BR
Brazil
Prior art keywords
release
prolonged release
well
pharmaceutical implant
administration process
Prior art date
Application number
BR0016012-1A
Other languages
English (en)
Inventor
William M Moseley
Todd P Foster
Satish Kumar Singh
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BR0016012A publication Critical patent/BR0016012A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"IMPLANTE FARMACêUTICO CONTENDO COMPONENTES DE LIBERAçãO IMEDIATA E DE LIBERAçãO PROLONGADA, ALéM DE PROCESSO DE ADMINISTRAçãO". Implante farmacêutico para administração de uma substância biologicamente ativa que é feito de um componente de liberação imediata, preferivelmente contendo um agente de desintegração e um componente de liberação prolongada. O implante da presente invenção provê flexibilidade no ajuste de liberação do medicamento e um princípio mais rápido da liberação pode ser provido, juntamente com uma liberação prolongada de prazo maior. A razão de liberação da substância biologicamente ativa pode ser ajustada por controle das quantidades relativas do componente de liberação imediata e do componente de liberação prolongada.
BR0016012-1A 1999-12-16 2000-12-04 Implante farmacêutico contendo componentes de liberação imediata e de liberação prolongada, além de processo de administração BR0016012A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17121599P 1999-12-16 1999-12-16
PCT/US2000/030177 WO2001043749A2 (en) 1999-12-16 2000-12-04 Pharmaceutical implant containing immediate-release and sustained-release components and method of administration

Publications (1)

Publication Number Publication Date
BR0016012A true BR0016012A (pt) 2002-07-23

Family

ID=22622955

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0016012-1A BR0016012A (pt) 1999-12-16 2000-12-04 Implante farmacêutico contendo componentes de liberação imediata e de liberação prolongada, além de processo de administração

Country Status (12)

Country Link
US (1) US20020131988A1 (pt)
EP (1) EP1237556A2 (pt)
JP (1) JP2003517014A (pt)
KR (1) KR100715748B1 (pt)
AR (1) AR026986A1 (pt)
AU (1) AU783538B2 (pt)
BR (1) BR0016012A (pt)
CA (1) CA2391957A1 (pt)
MX (1) MXPA02005911A (pt)
NZ (1) NZ519575A (pt)
WO (1) WO2001043749A2 (pt)
ZA (1) ZA200204352B (pt)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6953586B1 (en) * 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
GB2379390B (en) * 2001-09-11 2005-01-26 Caretek Medical Ltd A novel drug delivery technology
DE10164510A1 (de) * 2001-12-20 2003-07-10 Schering Ag Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes
AU2003201410B2 (en) * 2002-01-24 2008-07-03 Virbac Corporation Sustained release pharmaceutical composition
US20040105889A1 (en) * 2002-12-03 2004-06-03 Elan Pharma International Limited Low viscosity liquid dosage forms
US9101540B2 (en) * 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
CA2916869A1 (en) 2004-06-12 2005-12-29 Jane C. Hirsh Abuse-deterrent drug formulations
WO2006078320A2 (en) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US20080102123A1 (en) * 2006-10-27 2008-05-01 Schachter Deborah M Self-gelling tunable drug delivery system
US8470360B2 (en) 2008-04-18 2013-06-25 Warsaw Orthopedic, Inc. Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
WO2009085952A1 (en) 2007-12-20 2009-07-09 Brookwood Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
US8956641B2 (en) * 2008-04-18 2015-02-17 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of inflammatory diseases
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
US20100015049A1 (en) * 2008-07-16 2010-01-21 Warsaw Orthopedic, Inc. Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents
WO2010144849A2 (en) * 2009-06-11 2010-12-16 Medtronic, Inc. Dissolvable pharmaceutical implant
JP2013505251A (ja) * 2009-09-17 2013-02-14 エボニック デグサ コーポレイション 放出プロファイルが異なるインプラントデバイス並びにその製造及び使用方法
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8758799B2 (en) * 2010-03-24 2014-06-24 Covidien Lp Therapeutic implant
US8758798B2 (en) * 2010-03-24 2014-06-24 Covidien Lp Therapeutic implant
US8758800B2 (en) * 2010-03-24 2014-06-24 Covidien Lp Therapeutic implant
US20110312927A1 (en) * 2010-06-18 2011-12-22 Satish Kumar Nachaegari Progesterone Containing Oral Dosage Forms and Related Methods
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US9211175B2 (en) 2010-07-08 2015-12-15 Covidien Lp Self-detachable medical devices
FR2962646B1 (fr) 2010-07-16 2012-06-22 Sofradim Production Prothese avec element radio-opaque
US9572907B2 (en) 2010-10-01 2017-02-21 Covidien Lp Implantable polymeric films
US8632839B2 (en) 2010-10-19 2014-01-21 Covidien Lp Methods of forming self-supporting films for delivery of therapeutic agents
US9861590B2 (en) 2010-10-19 2018-01-09 Covidien Lp Self-supporting films for delivery of therapeutic agents
US8920867B2 (en) 2010-10-19 2014-12-30 Covidien Lp Methods of forming self-supporting films for delivery of therapeutic agents
US9144634B2 (en) 2011-01-14 2015-09-29 Covidien Lp Medical device with intrapore films
FR2977790B1 (fr) 2011-07-13 2013-07-19 Sofradim Production Prothese pour hernie ombilicale
US8579924B2 (en) 2011-07-26 2013-11-12 Covidien Lp Implantable devices including a mesh and a pivotable film
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9782957B2 (en) 2011-08-24 2017-10-10 Covidien Lp Medical device films
US8932621B2 (en) 2011-10-25 2015-01-13 Covidien Lp Implantable film/mesh composite
US9005308B2 (en) 2011-10-25 2015-04-14 Covidien Lp Implantable film/mesh composite for passage of tissue therebetween
US9179994B2 (en) 2011-10-25 2015-11-10 Covidien Lp Implantable film/mesh composite
US10206769B2 (en) 2012-03-30 2019-02-19 Covidien Lp Implantable devices including a film providing folding characteristics
FR2992662B1 (fr) 2012-06-28 2014-08-08 Sofradim Production Tricot avec picots
FR2992547B1 (fr) 2012-06-29 2015-04-24 Sofradim Production Prothese pour hernie
AU2016284459B2 (en) 2015-06-22 2021-12-23 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
WO2017105512A1 (en) 2015-12-18 2017-06-22 Proinvet Innovations S.A. Formulations and methods for controlling the reproductive cycle and ovulation
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
CN110251737A (zh) * 2019-08-06 2019-09-20 湖南优感觉生物科技有限公司 一种添加了玻尿酸的乳胶避孕套
EP4001289B1 (en) 2020-11-19 2023-05-03 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of trenbolone and/or trenbolone acetate
EP4001288B1 (en) 2020-11-19 2025-05-07 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution and a irregular hexagon plates crystal habit
EP4000688B1 (en) 2020-11-19 2025-11-05 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution
HUE067496T2 (hu) 2020-12-08 2024-10-28 Ruminant Biotech Corp Ltd Az állatoknak szánt anyagok bejuttatására szolgáló eszközök és módszerek fejlesztése

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3417182A (en) * 1963-03-25 1968-12-17 Upjohn Co Compositions and treatments using 6-methyl - 16 - methylene - 17alpha - hydroxy-4,6-pregnadiene-3,20-dione 17-acetate
US3737521A (en) * 1970-12-09 1973-06-05 Goodrich Co B F Formulation for sustained release of a biological agent
FR2271832A1 (en) * 1974-05-22 1975-12-19 Dynachim Sarl Compsns. contg. sex hormones and their esters - for improving wt. gain in meat animals
FR2290906A1 (fr) * 1974-11-13 1976-06-11 Dick Pierre Nouvelles associations hormonales synergisees pour l'implantation d'animaux de boucherie
IE56979B1 (en) * 1984-02-14 1992-02-26 Drug Systems Res & Dev Subcutaneous implant
US5288496A (en) * 1990-05-15 1994-02-22 Stolle Research & Development Corporation Growth promoters for animals
US5227167A (en) * 1991-06-11 1993-07-13 Alza Corporation Long-term delivery device including hydrophobic loading dose
CO5140100A1 (es) * 1998-11-04 2002-03-22 Schering Corp Composiciones estimulantes del crecimiento mejoradas el crecimiento del ganado
US7767708B2 (en) * 1998-11-04 2010-08-03 Schering-Plough Animal Health Corp. Growth stimulant compositions
US6498153B1 (en) * 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition

Also Published As

Publication number Publication date
EP1237556A2 (en) 2002-09-11
ZA200204352B (en) 2003-10-01
AU783538B2 (en) 2005-11-03
AR026986A1 (es) 2003-03-05
JP2003517014A (ja) 2003-05-20
WO2001043749A2 (en) 2001-06-21
AU1756101A (en) 2001-06-25
WO2001043749A3 (en) 2002-01-03
US20020131988A1 (en) 2002-09-19
CA2391957A1 (en) 2001-06-21
MXPA02005911A (es) 2002-10-23
NZ519575A (en) 2003-11-28
KR100715748B1 (ko) 2007-05-08
KR20020068376A (ko) 2002-08-27

Similar Documents

Publication Publication Date Title
BR0016012A (pt) Implante farmacêutico contendo componentes de liberação imediata e de liberação prolongada, além de processo de administração
BR0112356A (pt) Formulações farmacêuticas tópicas e métodos de tratamento
BR9911656A (pt) Composição farmacêutica, processos para prevenção ou tratamento de diabetes em um mamìfero, para prevenção ou tratamento de complicações diabéticas em um mamìfero e para prevenção ou tratamento da tolerância a glicose prejudicada em um mamìfero, uso de um sensibilizador de insulina, e, proceso para reduzir os efeitos colaterais de um sensibilizador de insulina ou/ e um anorético administrado a um mamìfero diabético
BR0009770A (pt) Derivados de bisindóis indigóides capazes de penetrarem na membrana de células, formulação farmacêutica e utilização da mesma
BR0312007A (pt) Controle de taxa de administração transcutânea usando composições farmacêuticas amorfas
BR0315700A (pt) Dispositivo médico implantável que incorpora rapamicina deuterada para a aplicação controlada da mesma
BR9809453A (pt) Composição de suprimento de medicamento para a liberação controlada de um ingrediente ativo dentro do meio-ambiente do estÈmago, uso da mesma, formulação farmacêutica, processo para obter gastrorretenção, para o tratamento ou profilaxia de uma doença, para melhorar a absorção gastrointestinal de medicamentos, e para a preparação de uma composição, e, estojo de partes para uso no tratamento de infecção por h. pylori.
BRPI0110914B8 (pt) 'composição farmacêutica líquida, processo para preparação da mesma e uso de uma composicão farmacêutica'
BR0209658A (pt) Derivados de 4-amino-5-fenil-7-1ciclobutil-pirrolo [2,3-d] pirimidina
BR0012136A (pt) Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
BR0307893A (pt) Formulação oftálmica com sistema de goma
BR0014928A (pt) Dispositivo e processo para distribuição de medicamento para um olho humano
ES2193159T3 (es) Una formulacion de factor de coagulacion viii.
BRPI0407485A (pt) utilização de anticorpos anti-receptores de factor crescimento i semelhantes aos anti-insulina
BR9906581A (pt) Processo para administração de taxano encapsulado em lipossomos
BR0307540A (pt) Preparação farmacêutica em forma de filme ou em forma de lâmina para administrar substâncias ativas, uso da preparação farmacêutica e processo para a administração oral de substância(s) farmaceuticamente ativa(s) dotadas de sabor amargo
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
BR0009437A (pt) Amido pré-gelatinizado em uma formulação de liberação controlada
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
ES2125324T3 (es) Film para suministro local de un farmaco para un tratamiento periodontal.
DE60211139D1 (de) Feste arzneizusammensetzung enthaltend 4'-cyano-trifluoro-3-(4-fluorophenylsulphonyl) -2-hydroxy-2-methylpropiono- m toluidide und pvp
BR9401199A (pt) Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento.
BR0315082A (pt) Preparação sólida
BR0114272A (pt) Formulação farmacêutica de liberação prolongada independente da força iÈnica
HRP20010684B1 (hr) Izravno stlaciva matrica za kontrolirano otpustanje jednostruke dnevne doze klaritromicina

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10(VIII), 11, 13 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.